U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07619183) titled 'A Study to Evaluate the Multiple Dose Ascending of PG-033 in Healthy Adult Participants.' on May 20.
Brief Summary: The goal of this study is to evaluate the safety, tolerability and pharmacokinetics (PK) profiles of multiple ascending oral doses(MAD) of PG-033 by directly comparing it with placebo.
Study Start Date: June 04
Study Type: INTERVENTIONAL
Condition:
Lichen Simplex Chronicus
Intervention:
DRUG: PG-033 tablets
Oral tablets (2mg, 10mg)
DRUG: PG-033 placebo comparator
Oral tablets (2mg, 10mg) (matching corresponding study medication)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Prime Gene Therapeutics Co., Ltd....